Targeted Oncology9h
Therapeutic options for a patient with mCRPC after ADT + docetaxel
An expert discusses the therapeutic options included in the NCCN guidelines for metastatic castration-resistant prostate ...
Too Old to Operate16h
Talazoparib + Enzalutamide Tied to Improved Overall Survival in Metastatic Prostate Cancer
For patients with metastatic castration-resistant prostate cancer (mCRPC) unselected for homologous recombination repair (HRR ...